Advancements in Complex API Manufacturing

The Shift to Continuous Flow

Continuous flow chemistry is fundamentally altering the way we synthesize complex Active Pharmaceutical Ingredients (APIs). Unlike traditional batch processing, continuous flow allows for enhanced temperature control, superior mixing, and inherently safer handling of hazardous intermediates.

At PEC Pharma, we have integrated these systems into our R&D and scale-up pipelines, particularly for critical molecules like Silodosin and Lacosamide where chiral integrity is paramount.

Impact on Global Supply Chains

These technological investments translate to shortened lead times and higher yield consistencies. As generic drug demand grows across LATAM and African regions, having scalable API pipelines ensures that formulations reach patients without supply disruptions.

"By controlling the microscopic parameters of synthesis continuously, we eliminate the macroscopic uncertainties of batch variations." - Dr. Amit, Head of R&D